LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) › Cost of RevenueLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $410.14M2017: $390.56M2018: $445.89M2019: $476.56M2020: $120.68M2021: $61.94M2022: $72.20M2023: $75.28M2024: $86.41M2025: $88.57M$88.57M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$88.57M+2.5%2024$86.41M+14.8%2023$75.28M+4.3%2022$72.20M+16.6%2021$61.94M-48.7%2020$120.68M-74.7%2019$476.56M+6.9%2018$445.89M+14.2%2017$390.56M-4.8%2016$410.14M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share